460 related articles for article (PubMed ID: 11174383)
21. Treatment of cutaneous T-cell lymphomas (CTCL) with extracorporeal photochemotherapy--preliminary report.
Nagatani T; Matsuzaki T; Kim S; Baba N; Osawa J; Sugiyama A; Komatsu H; Ichiyama S; Takahashi Y; Miyamoto H
J Dermatol; 1990 Dec; 17(12):737-45. PubMed ID: 2086618
[TBL] [Abstract][Full Text] [Related]
22. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution.
Gottlieb SL; Wolfe JT; Fox FE; DeNardo BJ; Macey WH; Bromley PG; Lessin SR; Rook AH
J Am Acad Dermatol; 1996 Dec; 35(6):946-57. PubMed ID: 8959954
[TBL] [Abstract][Full Text] [Related]
23. [Cutaneous lymphomas].
Schad K; Baumann Conzett K; Cozzio A
Ther Umsch; 2010 Sep; 67(9):453-64. PubMed ID: 20806174
[TBL] [Abstract][Full Text] [Related]
24. Treatment of cutaneous T cell lymphoma stage II with interferon-alpha-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
Ann N Y Acad Sci; 2001 Sep; 941():210-3. PubMed ID: 11594576
[No Abstract] [Full Text] [Related]
25. Treatment of childhood cutaneous T-cell lymphoma with alpha-interferon plus PUVA.
Tay YK; Weston WL; Aeling JL
Pediatr Dermatol; 1996; 13(6):496-500. PubMed ID: 8987062
[TBL] [Abstract][Full Text] [Related]
26. Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience.
Jiang SB; Dietz SB; Kim M; Lim HW
Photodermatol Photoimmunol Photomed; 1999 Oct; 15(5):161-5. PubMed ID: 10540936
[TBL] [Abstract][Full Text] [Related]
27. Correlation of clinical responses with immunologic and morphologic characteristics in patients with cutaneous T-cell lymphoma treated with interferon alfa-2a.
Springer EA; Kuzel TM; Variakojis D; Kaul K; Rosen ST; Roenigk HH
J Am Acad Dermatol; 1993 Jul; 29(1):42-6. PubMed ID: 7686188
[TBL] [Abstract][Full Text] [Related]
28. Acitretin for the treatment of cutaneous T-cell lymphoma.
Cheeley J; Sahn RE; DeLong LK; Parker SR
J Am Acad Dermatol; 2013 Feb; 68(2):247-54. PubMed ID: 22917895
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides.
Ponte P; Serrão V; Apetato M
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):716-21. PubMed ID: 19929938
[TBL] [Abstract][Full Text] [Related]
30. Dose-escalation study evaluating pegylated interferon alpha-2a in patients with cutaneous T-cell lymphoma.
Schiller M; Tsianakas A; Sterry W; Dummer R; Hinke A; Nashan D; Stadler R
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1841-1847. PubMed ID: 28557110
[TBL] [Abstract][Full Text] [Related]
31. Extracorporeal photochemotherapy induces a significant increase in CD36+ circulating monocytes in patients with mycosis fungoides.
Fimiani M; Rubegni P; Pimpinelli N; Mori M; De Aloe G; Andreassi L
Dermatology; 1997; 194(2):107-10. PubMed ID: 9094456
[TBL] [Abstract][Full Text] [Related]
32. Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome.
Foss FM; Ihde DC; Linnoila IR; Fischmann AB; Schechter GP; Cotelingam JD; Steinberg SM; Ghosh BC; Stocker JL; Bastian A
J Clin Oncol; 1994 Oct; 12(10):2051-9. PubMed ID: 7931473
[TBL] [Abstract][Full Text] [Related]
33. Biologic correlates of response and survival in patients with cutaneous T-cell lymphoma treated with denileukin diftitox.
Chin KM; Foss FM
Clin Lymphoma Myeloma; 2006 Nov; 7(3):199-204. PubMed ID: 17229335
[TBL] [Abstract][Full Text] [Related]
34. [Photodynamic therapy of cutaneous T-cell lymphoma at special sites].
Eich D; Eich HT; Otte HG; Ghilescu V; Stadler R
Hautarzt; 1999 Feb; 50(2):109-14. PubMed ID: 10097953
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial.
Tacastacas JD; Chan DV; Carlson S; Gerson SL; Dowlati A; Fu P; Lu K; Groft S; Rosenjack J; Honda K; McCormick TS; Cooper KD
JAMA Dermatol; 2017 May; 153(5):413-420. PubMed ID: 28199478
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
37. Palliative local radiotherapy in the treatment of tumor-stage cutaneous T-cell lymphoma/mycosis fungoides.
Xu CC; Zhang T; Wang T; Liu J; Liu YH
Chin Med Sci J; 2014 Mar; 29(1):33-7. PubMed ID: 24698676
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients.
Song H; Hu Z; Zhang S; Yang L; Feng J; Lu L; Liu Y; Wang T
J Dermatolog Treat; 2024 Dec; 35(1):2350231. PubMed ID: 38754985
[No Abstract] [Full Text] [Related]
39. The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.
Spaccarelli N; Rook AH
Dermatol Clin; 2015 Oct; 33(4):731-45. PubMed ID: 26433845
[TBL] [Abstract][Full Text] [Related]
40. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]